Literature DB >> 12711747

Oncogenic osteomalacia--a complex dance of factors.

Thomas O Carpenter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711747     DOI: 10.1056/NEJMe030037

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  Tumor-induced osteomalacia.

Authors:  Mala Kaul; Miriam Silverberg; Edward F Dicarlo; Robert Schneider; Anne R Bass; Doruk Erkan
Journal:  Clin Rheumatol       Date:  2007-01-16       Impact factor: 2.980

2.  Oncogenic hypophosphataemic osteomalacia mimicking bone metastases on isotope bone scan.

Authors:  J K Dowman; F H Khattak
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

3.  Severe, reversible dysphagia and malnutrition in a patient with tumour-induced hypophosphataemia.

Authors:  Tone Ramsli; Jørgen Valeur; Mikkel Pretorius; Per Gerlyng
Journal:  BMJ Case Rep       Date:  2018-06-27

Review 4.  Dual paraneoplastic syndromes: small cell lung carcinoma-related oncogenic osteomalacia, and syndrome of inappropriate antidiuretic hormone secretion: report of a case and review of the literature.

Authors:  Ekamol Tantisattamo; Roland C K Ng
Journal:  Hawaii Med J       Date:  2011-07

5.  Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status.

Authors:  Thomas O Carpenter; Karl L Insogna; Jane H Zhang; Bruce Ellis; Sherril Nieman; Christine Simpson; Elizabeth Olear; Caren M Gundberg
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

6.  Secondary hyperparathyroidism as a palpable intrathyroid parathyroid gland in a patient with hypophosphatemic osteomalacia.

Authors:  Deng-Huang Su; Kuo-Meng Liao; Ying-Chun Chang; Keh-Sung Tsai
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

7.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

Authors:  Despina Sitara; Mohammed S Razzaque; Martina Hesse; Subbiah Yoganathan; Takashi Taguchi; Reinhold G Erben; Harald Jüppner; Beate Lanske
Journal:  Matrix Biol       Date:  2004-11       Impact factor: 11.583

Review 8.  Paraneoplastic endocrine syndromes: a review.

Authors:  Ronald A DeLellis; Ling Xia
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

9.  Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia.

Authors:  Regina S Bower; Wilson P Daugherty; Caterina Giannini; Ian F Parney
Journal:  Surg Neurol Int       Date:  2012-12-14

10.  The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?

Authors:  Cameron K Ledford; Nicole A Zelenski; Diana M Cardona; Brian E Brigman; William C Eward
Journal:  Clin Orthop Relat Res       Date:  2013-07-19       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.